Article

Quality Enterprise Roundtable

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
4 experts in this video
4 experts in this video
Related Content
Most Favored Nation | Image Credit: © AliFuat-stock.adobe.com
September 12th 2025

Unpacking the Complexity of the Most Favored Nation Mandate

Maggie L. Shaw
Managed Care Cast thumbnail
September 12th 2025

Navigating the Alzheimer Disease Blood Test Revolution

Maggie L. Shaw Howard Fillit, MD Anthony "Nino" Sireci, MD, MSc
Researchers identified NUDT21, also known as CFIm25, as a key regulator of senescence-associated pathways in fibroblasts. | Image credit: Vitalii Vodolazskyi - stock.adobe.com
September 12th 2025

Senescent Fibroblasts in IPF Linked to NUDT21 Deficiency

Kimberly Rath, PharmD
Managed Care Cast Logo
September 12th 2025

AI in Health Care: Balancing Governance, Innovation, and Trust

Maggie L. Shaw Reuben Daniel
Bijal Shah, MD, MS | Image: Moffitt Cancer Center
September 12th 2025

Indirect Comparison Finds Zanubrutinib Associated With Better PFS, OS Than Acalabrutinib in MCL

Mary Caffrey
Previous randomized controlled trials have established mepolizumab’s efficacy, but the new study aimed to analyze its performance in a diverse, real-world patient population. | Image credit: luchschenF - stock.adobe.com
September 12th 2025

Real-World Study Reinforces Mepolizumab's Effectiveness in Severe Eosinophilic Asthma

Rose McNulty

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo